고관절 주위 골절 후에 골다공증 치료의 결과 = Results of Osteoporotic Treatment Drug after Periarticular Fracture of Hip

다국어 초록 (Multilingual Abstract)

Purpose: The Purpose of the study is to know patients` compliance of drug treatment of osteoporosis after operation of fracture and to compare of accompanying fractures between patients who diagnosed with osteoporosis itself and had the drug treatment of osteoporosis after surgery of periarticular fracture of hip. Materials and Methods: In experimental group, consecutive 60 patients who had fracture of femoral neck and trochanter. And in control group, 61 patients diagnosed osteoporosis with drug treatment within the same period in orthopedic department from July 2006 to July 2007. The average age is 73.8 (±6.7) year in experimental group, and 66.6 (±7.46) year in control group. Both groups had at least a year follow-up with drug treatment and had BMD again at least a year later. Results: BMD test in experimental group showed -3.05 (±1.35) preoperatively and -2.74 (±1.50) in last follow-up. BMD test in control group showed -3.55 (±0.52) in initial administration and -3.10 (±0.87) in last follow-up. The results showed a significant improvement in statistical analysis (p=0.0002, p＜0.0001). Conclusion: The compliance of drug treatment of osteoporosis after operation of periarticular fracture of hip is the same as in patients` diagnosed osteoporosis.

참고문헌 (Reference)

1 김동휘, "골다공증이 있는 고령의 대퇴부 전자간 골절에서 근위 골수강내 고정술을 이용한 치료" 대한골절학회 20 (20): 215-221, 2007

2 정화재, "골다공증을 동반한 고령 환자에서 불안정성 대퇴 전자간 골절의 금속 내 고정술과 양극성 반치환술의 결과 비교" 대한골절학회 20 (20): 291-296, 2007

3 Cadarette SM, "Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004" 35 : 319-326, 2004

4 Brankin E, "The impact of dosing frequency on compliance and persistence with bisphosphonates among postmenopausal women in the UK: evidence from three databases" 22 : 1249-1256, 2006

5 Caro JJ, "The impact of compliance with osteoporosis therapy on fracture rates in actual practice" 15 : 1003-1008, 2004

6 Wolinsky FD, "The effect of hip fracture on mortality, hospitalization, and functional status: a prospective study" 87 : 398-403, 1997

7 Colón-Emeric C, "The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies" 14 : 879-883, 2003

8 Trombetti A, "Survival and potential years of life lost after hip fracture in men and age-matched women" 13 : 731-737, 2002

9 van Helden S, "Risk of new clinical fractures within 2 years following a fracture" 17 : 348-354, 2006

10 Bruyere O, "Post-fracture management of patients with hip fracture: a perspective" 24 : 2841-2851, 2008

11 Cooper C, "Population-based study of survival after osteoporotic fractures" 137 : 1001-1005, 1993

12 Klotzbuecher CM, "Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis" 15 : 721-739, 2000

13 Zethraeus N, "Models for assessing the cost-effectiveness of the treatment and prevention of osteoporosis" 13 : 841-857, 2002

14 Penning-van Beest FJ, "Loss of treatment benefit due to low compliance with bisphosphonate therapy" 19 : 511-517, 2008

15 Boonen S, "Functional outcome and quality of life following hip fracture in elderly women: a prospective controlled study" 15 : 87-94, 2004

16 Kertes J, "Factors contributing to compliance with osteoporosis medication" 10 : 207-213, 2008

17 Blouin J, "Discontinuation of antiresorptive therapies: a comparison between 1998-2001 and 2002-2004 among osteoporotic women" 92 : 887-894, 2007

18 Penning-van Beest FJ, "Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis" 28 : 236-242, 2006

19 Autier P, "Costs induced by hip fractures: a prospective controlled study in Belgium. Belgian Hip Fracture Study Group" 11 : 373-380, 2000

20 Weycker D, "Compliance with osteoporosis drug therapy and risk of fracture" 18 : 271-277, 2007

21 McCombs JS, "Compliance with drug therapies for the treatment and prevention of osteoporosis" 48 : 271-287, 2004

22 Cramer JA, "Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis" 21 : 1453-1460, 2005

23 Haentjens P, "Belgian Hip Fracture Study Group: The economic cost of hip fractures among elderly women. A one-year, prospective, observational cohort study with matched-pair analysis. Belgian Hip Fracture Study Group" 83 : 493-500, 2001

24 Huybrechts KF, "Assessment of compliance with osteoporosis treatment and its consequences in a managed care population" 38 : 922-928, 2006

25 Siris ES, "Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases" 81 : 1013-1022, 2006

26 Cramer JA, "A systematic review of persistence and compliance with bisphosphonates for osteoporosis" 18 : 1023-1031, 2007

27 Schurch MA, "A prospective study on socioeconomic aspects of fracture of the proximal femur" 11 : 1935-1942, 1996